tiprankstipranks
Trending News
More News >
Scandinavian Real Heart AB (SE:HEART)
:HEART

Scandinavian Real Heart AB (HEART) AI Stock Analysis

Compare
1 Followers

Top Page

SE

Scandinavian Real Heart AB

(Frankfurt:HEART)

Rating:34Underperform
Price Target:
Scandinavian Real Heart AB is facing significant financial and operational challenges, reflected in its low financial performance score due to ongoing losses and cash flow issues. The technical analysis presents mixed signals with no clear trend. Valuation metrics are unfavorable, with a negative P/E ratio indicating financial distress. These factors combine to create a cautious outlook for the stock, requiring significant operational improvements and strategic adjustments to enhance performance and investor confidence.

Scandinavian Real Heart AB (HEART) vs. iShares MSCI Sweden ETF (EWD)

Scandinavian Real Heart AB Business Overview & Revenue Model

Company DescriptionScandinavian Real Heart AB (HEART) is a Swedish medical technology company focused on developing advanced cardiac assist devices. The company specializes in creating innovative artificial heart solutions designed to improve the quality of life for patients with severe heart diseases. Their flagship product, the Total Artificial Heart, aims to replicate the functionality of a natural heart, providing a life-saving option for patients awaiting heart transplants.
How the Company Makes MoneyScandinavian Real Heart AB primarily generates revenue through the development and commercialization of its Total Artificial Heart technology. This involves securing partnerships with healthcare institutions and medical device distributors who facilitate the adoption and implementation of their products in clinical settings. Additionally, the company may receive funding through grants, research collaborations, and strategic alliances with larger medical technology firms. As the product progresses through clinical trials and regulatory approvals, sales and licensing agreements are expected to become significant revenue streams.

Scandinavian Real Heart AB Financial Statement Overview

Summary
Scandinavian Real Heart AB faces significant financial challenges, particularly in generating revenue and achieving profitability. The balance sheet shows relative stability, although increasing leverage is a concern. Persistent negative cash flows underscore the need for improved cash management or additional financing. Overall, the financial outlook requires careful monitoring and strategic adjustments to address these issues.
Income Statement
15
Very Negative
Scandinavian Real Heart AB has struggled to generate revenue, with total revenue consistently at or near zero in recent years. The company also reports persistent negative net income and EBIT margins, highlighting ongoing challenges in achieving profitability. The lack of revenue growth and negative profit margins suggest significant operational difficulties.
Balance Sheet
45
Neutral
The company's balance sheet shows a high equity ratio, indicating a solid financial base with stockholders' equity making up the majority of total assets. However, the debt-to-equity ratio has been increasing, suggesting rising leverage. Despite this, the overall financial stability appears reasonable, though the lack of revenue raises concerns about future financial health.
Cash Flow
20
Very Negative
Cash flow analysis reveals ongoing negative free cash flow, driven by substantial capital expenditures and negative operating cash flow. The company's reliance on external financing is evident, raising concerns about sustainability. Operating cash flow is negative compared to net income, which may indicate cash flow management issues.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
0.000.0010.00K0.000.00
Gross Profit
-19.18M-50.22M12.29M7.20M332.76K
EBIT
-34.15M-68.45M-13.85M-10.33M-8.64M
EBITDA
-14.52M-67.25M-13.73M-10.09M-8.37M
Net Income Common Stockholders
-34.35M-67.98M-13.99M-10.48M-8.82M
Balance SheetCash, Cash Equivalents and Short-Term Investments
23.72M43.30M11.26M42.67M22.45M
Total Assets
83.28M102.64M119.82M117.82M78.04M
Total Debt
6.35M8.25M2.17M2.80M3.42M
Net Debt
-17.36M-35.05M-9.09M-39.88M-19.04M
Total Liabilities
15.94M20.60M22.17M6.53M6.35M
Stockholders Equity
67.34M82.04M97.65M111.29M71.69M
Cash FlowFree Cash Flow
-38.25M-26.82M-31.14M-29.24M-24.18M
Operating Cash Flow
-12.99M-25.05M-7.38M-9.65M-9.41M
Investing Cash Flow
-24.28M-1.77M-23.76M-19.59M-14.76M
Financing Cash Flow
17.69M58.87M-276.28K49.46M21.21M

Scandinavian Real Heart AB Technical Analysis

Technical Analysis Sentiment
Negative
Last Price13.90
Price Trends
50DMA
14.60
Negative
100DMA
15.41
Negative
200DMA
16.86
Negative
Market Momentum
MACD
-0.23
Positive
RSI
41.86
Neutral
STOCH
29.37
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:HEART, the sentiment is Negative. The current price of 13.9 is below the 20-day moving average (MA) of 14.43, below the 50-day MA of 14.60, and below the 200-day MA of 16.86, indicating a bearish trend. The MACD of -0.23 indicates Positive momentum. The RSI at 41.86 is Neutral, neither overbought nor oversold. The STOCH value of 29.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:HEART.

Scandinavian Real Heart AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
kr1.15B35.4910.11%2.53%-44.90%
54
Neutral
$5.31B3.28-45.10%2.80%16.76%0.02%
50
Neutral
€311.20M-159.24%-22.50%76.74%
46
Neutral
€255.30M-88.97%-0.61%54.19%
46
Neutral
€1.05B-7.30%23.51%80.47%
SELXB
37
Underperform
kr97.29M-51.52%955.20%47.31%
34
Underperform
kr69.48M
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:HEART
Scandinavian Real Heart AB
13.60
-25.60
-65.31%
SE:ACARIX
Acarix AB
0.24
-0.09
-26.15%
SE:BACTI.B
Bactiguard Holding AB
30.60
-40.80
-57.14%
SE:CRAD.B
C-Rad AB Class B
34.15
-8.70
-20.30%
SE:LXB
Luxbright AB
0.74
-0.21
-22.51%
SE:QLINEA
Q-linea AB
0.05
-0.49
-91.08%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.